{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:57:14Z","timestamp":1770469034483,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,5]]},"DOI":"10.7759\/cureus.103031","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T15:59:17Z","timestamp":1770307157000},"source":"Crossref","is-referenced-by-count":0,"title":["Significance of Genetic Testing in Diagnosing Cholestatic Disease in Infants"],"prefix":"10.7759","author":[{"given":"Mahnoor","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Umair","family":"Shehzad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umaima  M","family":"Khattak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nida","family":"Zeeshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iqtadar","family":"Seerat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.37349\/edd.2022.00010","article-title":"Cholestasis associated with inborn errors in bile acid synthesis","volume":"1","author":"Espinosa-Escudero R","year":"2022","unstructured":"Espinosa-Escudero R, Herraez E, Sanchez-Martin A, Sanchon-Sanchez P, Marin JG, Monte MJ. Cholestasis associated with inborn errors in bile acid synthesis. Explor Dig Dis. 2022, 1:137-53. 10.37349\/edd.2022.00010","journal-title":"Explor Dig Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5812\/ijp-133741","article-title":"Bile acid synthesis disorder, the first reported case from Iran, (proven by genetic study), how the unavailability of drug affected the course of treatment","volume":"33","author":"Mahjoub FE","year":"2023","unstructured":"Mahjoub FE, Motamed F, Niknejad N,  Farahmand F, Hadipour F, Asili P. Bile acid synthesis disorder, the first reported case from Iran, (proven by genetic study), how the unavailability of drug affected the course of treatment. Iran J Pediatr. 2023, 33:e133741. 10.5812\/ijp-133741","journal-title":"Iran J Pediatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jcag\/gwad061.104","article-title":"Atypical presentation of HSD3B7 deficiency","volume":"7","author":"Morrissey M","year":"2024","unstructured":"Morrissey M, Kawada P. Atypical presentation of HSD3B7 deficiency. J Can Assoc Gastroenterol. 2024, 7:75-6. 10.1093\/jcag\/gwad061.104","journal-title":"J Can Assoc Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2024-0454","article-title":"Expanding the genotypic spectrum of 3\u03b2-hydroxy-\u03b45-C27-steroid dehydrogenase (HSD3B7) deficiency: novel mutations and clinical outcomes","volume":"38","author":"Yolda\u015f \u00c7elik M","year":"2025","unstructured":"Yolda\u015f \u00c7elik M, K\u00f6\u015feci B, Burga\u00e7 E, et al.. Expanding the genotypic spectrum of 3\u03b2-hydroxy-\u03b45-C27-steroid dehydrogenase (HSD3B7) deficiency: novel mutations and clinical outcomes. J Pediatr Endocrinol Metab. 2025, 38:546-50. 10.1515\/jpem-2024-0454","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-02041-7","article-title":"Genetic spectrum and clinical characteristics of 3\u03b2-hydroxy-\u0394(5)-C(27)-steroid oxidoreductase (HSD3B7) deficiency in China","volume":"16","author":"Zhao J","year":"2021","unstructured":"Zhao J, Setchell KD, Gong Y, et al.. Genetic spectrum and clinical characteristics of 3\u03b2-hydroxy-\u0394(5)-C(27)-steroid oxidoreductase (HSD3B7) deficiency in China. Orphanet J Rare Dis. 2021, 16:417. 10.1186\/s13023-021-02041-7","journal-title":"Orphanet J Rare Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03449-7","article-title":"The clinical and biochemical effectiveness and safety of cholic acid treatment for bile acid synthesis defects: a systematic review","volume":"19","author":"Polak Y","year":"2024","unstructured":"Polak Y, van Dussen L, Kemper EM, Vaz FM, Klouwer FC, Engelen M, Hollak CE. The clinical and biochemical effectiveness and safety of cholic acid treatment for bile acid synthesis defects: a systematic review. Orphanet J Rare Dis. 2024, 19:466. 10.1186\/s13023-024-03449-7","journal-title":"Orphanet J Rare Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2024.101166","article-title":"Efficacy and safety of switching therapy from chenodeoxycholic acid to cholic acid in Japanese patients with bile acid synthesis disorders","volume":"41","author":"Suzuki M","year":"2024","unstructured":"Suzuki M, Takei H, Suzuki H, et al.. Efficacy and safety of switching therapy from chenodeoxycholic acid to cholic acid in Japanese patients with bile acid synthesis disorders. Mol Genet Metab Rep. 2024, 41:101166. 10.1016\/j.ymgmr.2024.101166","journal-title":"Mol Genet Metab Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.70062","article-title":"Effectiveness and safety of personalized cholic acid treatment in patients with bile acid synthesis defects","volume":"48","author":"Polak Y","year":"2025","unstructured":"Polak Y, Kemper EM, Engelen M, et al.. Effectiveness and safety of personalized cholic acid treatment in patients with bile acid synthesis defects. J Inherit Metab Dis. 2025, 48:e70062. 10.1002\/jimd.70062","journal-title":"J Inherit Metab Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002618","article-title":"Open-label Phase 3 continuation study of cholic acid in patients with inborn errors of bile acid synthesis","volume":"70","author":"Heubi JE","year":"2020","unstructured":"Heubi JE, Setchell KD. Open-label Phase 3 continuation study of cholic acid in patients with inborn errors of bile acid synthesis. J Pediatr Gastroenterol Nutr. 2020, 70:423-9. 10.1097\/MPG.0000000000002618","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00149","article-title":"Pediatric cholestatic liver disease: review of bile acid metabolism and discussion of current and emerging therapies","volume":"7","author":"Kriegermeier A","year":"2020","unstructured":"Kriegermeier A, Green R.  Pediatric cholestatic liver disease: review of bile acid metabolism and discussion of current and emerging therapies. Front Med (Lausanne). 2020, 7:149. 10.3389\/fmed.2020.00149","journal-title":"Front Med (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/449186-significance-of-genetic-testing-in-diagnosing-cholestatic-disease-in-infants","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T15:59:17Z","timestamp":1770307157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/449186-significance-of-genetic-testing-in-diagnosing-cholestatic-disease-in-infants"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.103031","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,5]]}}}